De-escalation of bone-modifying agents in patients with bone metastases from breast cancer: a systematic review and meta-analysis.

Arif Ali AwanBrian HuttonJohn HiltonSasha MazzarelloCatherine Van PoznakLisa VandermeerBrianne BotaCarol StoberMarta SienkiewiczDean FergussonRisa ShorrMark Clemons

Published in: Breast cancer research and treatment (2019)

These data are supportive of de-escalation of zoledronate from onset for patients with bone metastases from breast cancer.

Keyphrases

open label
bone mineral density
electronic health record
big data
soft tissue
postmenopausal women
breast cancer risk
bone loss
body composition
artificial intelligence